Gregoire Prevost
15Patents
3h-index
20Co-inventors
56Inventor score
Filing activity: Nov 8, 2000 → Apr 16, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8017637B2 | Inhibitors of cdc phosphatases | Chemistry; Metallurgy | 8 | Active |
| US7795284B2 | 4,7-dioxobenzothiazole-2-carboxamide derivatives, their preparation and their therapeutic uses | Chemistry; Metallurgy | 8 | Active |
| US8188133B2 | Imidazole derivatives, preparation and user thereof as medicine | Human Necessities | 7 | Active |
| US7279467B2 | Benzothiazole-and benzoxazole-4, 7-dione derivatives and their use as dcd25 phosphatase inhibitors | Chemistry; Metallurgy | 3 | Expired |
| US6544995B1 | Use of cysteine derivatives for preparing a medicine for treating pathologies resulting from the formation of heterotrimeric G protein | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7495021B2 | Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors | Chemistry; Metallurgy | 1 | Active |
| US6846822B2 | Product comprising a heterotrimeric G protein signal transduction inhibitor associated with anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension | Human Necessities | 1 | Expired |
| US7034024B1 | Product inhibiting transduction of G heterotrimeric protein signals combined with another anti-cancer agent for therapeutic use in cancer treatment | Human Necessities | 1 | Expired |
| US8624037B2 | Imidazolidine-2,4-dione derivatives and use thereof as a medicament | Chemistry; Metallurgy | 1 | Active |
| US7132553B2 | Product comprising an inhibitor of the transduction of heterotrimeric G protein signals combined with an anti-hypertensive agent for therapeutic use in the treatment of arterial hypertension | Human Necessities | 0 | Expired |
| US7196084B2 | Cdc25 phosphatase inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US6887869B2 | Mikanolide derivatives, their preparation and therapeutic uses | Human Necessities | 0 | Expired |
| US7034025B2 | Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein | Emerging Cross-Sectional Technologies | 0 | Expired |
| US7091239B2 | DNA polymerase inhibitors, mikanolide and dihydromikanolide | Emerging Cross-Sectional Technologies | 0 | Expired |
| US6767561B2 | DNA polymerase inhibitors, mikanolide and dihydromikanolide | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.